NORTH CHICAGO, Ill.,
Feb. 15, 2017 /PRNewswire/ -- AbbVie
(NYSE: ABBV) will participate in the Cowen and Company 37th Annual
Health Care Conference on Wednesday, March
8, 2017. William Chase,
executive vice president and chief financial officer, will present
at 8:20 a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie is a global, research-based
biopharmaceutical company formed in 2013 following separation from
Abbott Laboratories. The company's mission is to use its expertise,
dedicated people and unique approach to innovation to develop and
market advanced therapies that address some of the world's most
complex and serious diseases. Together with its wholly-owned
subsidiary, Pharmacyclics, AbbVie employs approximately 30,000
people worldwide and markets medicines in more than 170 countries.
For further information on the company and its people, portfolio
and commitments, please visit www.abbvie.com. Follow @abbvie on
Twitter or view careers on our Facebook or LinkedIn page.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-cowen-and-company-37th-annual-health-care-conference-300407536.html
SOURCE AbbVie